Delivery Order SPE2DB20D1004-SPE2DB25FNLBE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Menquadfi vial 0.5ml pharmaceutical products. This firm fixed-price delivery order, valued at $5,085.08, is due for completion by September 19, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award was made on a competitive basis without set-aside provisions, reflecting AmerisourceBergen's demonstrated capability to meet federal...
- The Defense Logistics Agency awarded a delivery order valued at $18,365.68 to AmerisourceBergen Drug Corp for the supply of Menquadfi vials (0.5ML) on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $3,656.00 to AmerisourceBergen Drug Corp for the supply of Menquadfi vials (0.5mL) on August 18, 2025, with a completion date of August 19, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger federal contract vehicle. The place of performance is listed as Conshohocken, Pennsylvania, which serves as the company's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $29,333.15 to AmerisourceBergen Drug Corp for Menquadfi vial 0.5ML on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively bid with no set-aside designation and will...
- The Defense Logistics Agency awarded a delivery order valued at $7,264.50 to AmerisourceBergen Drug Corp for the supply of Menquadfi vials (0.5mL) with a firm fixed price arrangement. The award was made on August 19, 2025, with an ultimate completion date of August 20, 2025, and represents a non-set-aside, competitively awarded procurement. Performance will be executed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for MENQUADFI vials (0.5ML) with a ceiling value of $8,254.21 under a firm fixed-price contract type. The award was made on August 11, 2025, with an ultimate completion date of August 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a competitively awarded, non-set-aside delivery order issued under...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $65,228.60 to AmerisourceBergen Drug Corp for the supply of Menquadfi vials (0.5ML) with an ultimate completion date of September 17, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, is...
- The Defense Logistics Agency awarded a delivery order valued at $1,452.88 to AmerisourceBergen Drug Corp for the supply of Menquadfi vial 0.5ML on June 2, 2025, with an ultimate completion date of June 3, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and is to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,179.32 to AmerisourceBergen Drug Corp for the supply of Menquadfi vials (0.5mL) to support federal medical procurement needs. This non-competitive delivery order, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a firm fixed-price transaction under a larger contract vehicle. The work will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,905.80 to AmerisourceBergen Drug Corp for Menquadfi vial 0.5mL pharmaceutical products on June 5, 2025, with completion targeted for June 6, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, was selected...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB25FNLBEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $45,907.20 to AmerisourceBergen Drug Corp for the supply of Menquadfi vials (0.5ML) on September 25, 2025, with an ultimate completion date of September 26, 2025. This competitively awarded, firm fixed-price contract requires performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. No set-aside provisions were utilized in this award. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a maximum value of $999,999,999.00 and extends through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen maintains an extensive portfolio of federal contract awards predominately with the Defense Logistics Agency Medical Supply Chain, delivering specialty medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $45.9k | 9/25/25 |